By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Helix Biopharma Corp. 

3-305 Industrial Parkway

Aurora  Ontario  L4G 6X7  Canada
Phone: 905-841-2300-Ext-232 Fax: 905-841-2244


SEARCH JOBS


Industry
Biotechnology

Segment
Vaccines





Company News
Helix Biopharma (CC:HBP) Initiates Enrollment For Ninth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47 7/15/2014 11:33:21 AM
Helix Biopharma (CC:HBP) Announces Completion Of Private Placement 7/14/2014 1:38:18 PM
Helix Biopharma (CC:HBP) Announces The Receipt Of Subscription Agreements For A Net CAD5.4 Million Private Placement 7/8/2014 12:17:45 PM
Helix Biopharma (CC:HBP) Announces Fiscal Q3 2014 Results 6/13/2014 8:37:24 AM
Helix Biopharma (CC:HBP) Submits L-DOS47 Clinical Trial Application With Health Canada 5/14/2014 9:51:51 AM
Helix Biopharma (CC:HBP) Receives U.S. FDA Approval To Initiate A Clinical Trial Of L-DOS47 In Combination With Pemetrexed And Carboplatin 4/22/2014 8:45:41 AM
Helix Biopharma (CC:HBP) Initiates Enrollment For Eighth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47 4/8/2014 10:24:35 AM
Helix Biopharma (CC:HBP) Submits L-DOS47 Investigational New Drug Application With FDA 4/4/2014 10:09:19 AM
Helix Biopharma (CC:HBP) Announces Fiscal Q2 2014 Results 3/17/2014 11:02:10 AM
Helix Biopharma (CC:HBP) Announces Appointment Of New Director And Observer To The Board of Directors 3/12/2014 10:11:38 AM
12345678910...
//-->